Mingyi Zhushou

Mingyi Zhushou Group is a smart medical empowerment platform in China, with multiple branches and subsidiaries in Beijing, Anhui, Guangdong, Shandong, Shanxi, and other places. Under the leadership of founder and CEO Su Shu, the group actively responds to the national call to "solve the difficulty and high cost of seeing a doctor," deeply cultivating the "Internet + healthcare" field for nearly 10 years, building a platform that can continuously provide scientific and smart medical services to patients. Currently, the company has signed contracts with over 30,000 experts at or above the level of associate chief physician from top-tier hospitals in China and abroad, 100,000 grassroots doctors, and over 1,000 grassroots cooperative hospitals.
On this basis, the company exports first-tier quality medical resources to third- and fourth-tier cities in the form of "famous doctors, famous departments, and famous hospitals," effectively improving the medical level in lower-tier markets. At the same time, the platform cooperates closely with well-known medical institutions at home and abroad, including Memorial Sloan Kettering Cancer Center in the United States, Singapore's Parkway Health Group, Peking Union Medical College Hospital, Tsinghua Changgung Hospital, Shanghai Eastern Hepatobiliary Surgery Hospital, and the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, to empower and operate regional bases and provide medical services with deep integration of online and offline. In addition, to better meet the growing medical and health needs of the public and smooth doctor-patient communication, the company entered the medical IP cultivation field last year, successfully nurturing a group of "internet-famous doctors" such as Obstetrics and Gynecology Laowu and Director Zhang Wenhe, with a total of tens of millions of subscribers.
In recent years, the company has continuously upgraded and optimized its strategies and tactics. On the basis of accumulating medical resources, it has invested in and acquired medical device and consumables companies, private hospitals (already owning two), medical MCN institutions, and related medical enterprises. The group takes the lead in integrating advantageous resources to further form a closed loop in the big health industry.
In 2022, Mingyi Zhushou successfully obtained the "Internet Hospital" license granted by the National Health Commission, not only becoming one of the few "Internet+" enterprises holding this license, but also further aligning its business with national policies.
As of now, the group has completed Series C financing, successfully attracting hundreds of millions of yuan in investments from star funds such as Fosun Pharma, ZhenFund, Gaorong Capital, and Yueyin Capital. At the same time, with the support of investors, the company has reached in-depth strategic cooperation with multiple platforms including Ali Health, Ping An Good Doctor, Daan Diagnostics, and Shuidichou. Looking to the future, the company will continue to expand its global influence and visibility, strengthen connections with advanced overseas medical resources, and help continuously improve the national medical and health level.